Skip to main content
. 2012 Mar 14;2012(3):CD007176. doi: 10.1002/14651858.CD007176.pub2

Comparison 1. Antioxidants versus placebo or no intervention.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality in trials with a low or high risk of bias 78 296707 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.98, 1.05]
1.1 Trials with low risk of bias 56 244056 Risk Ratio (M‐H, Random, 95% CI) 1.04 [1.01, 1.07]
1.2 Trials with high risk of bias 22 52651 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.85, 0.98]
2 Mortality in 76 trials with a low or high risk of bias with assigned fatalities to all of the dropouts 76 263805 Risk Ratio (M‐H, Random, 95% CI) 1.01 [0.99, 1.03]
2.1 Trials with low risk of bias 55 240738 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.99, 1.04]
2.2 Trials with high risk of bias 21 23067 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.86, 0.99]
3 Mortality in primary and secondary prevention trials with a low or high risk of bias 78 296707 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.98, 1.05]
3.1 Primary prevention trials with a low risk of bias 19 177868 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.97, 1.08]
3.2 Secondary prevention trials with a low risk of bias 37 66188 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.99, 1.07]
3.3 Primary prevention trials with a high risk of bias 7 38032 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.84, 1.03]
3.4 Secondary prevention trials with a high risk of bias 15 14619 Risk Ratio (M‐H, Random, 95% CI) 0.90 [0.81, 0.99]
4 Mortality after excluding trials administrating extra supplements in the antioxidant group 60 249526 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.99, 1.06]
4.1 Trials with low risk of bias 43 227700 Risk Ratio (M‐H, Random, 95% CI) 1.04 [1.01, 1.07]
4.2 Trials with high risk of bias 17 21826 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.82, 1.00]
5 Mortality after excluding trials with extra supplements for both intervention groups 63 283619 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.99, 1.05]
5.1 Trials with low risk of bias 48 233249 Risk Ratio (M‐H, Random, 95% CI) 1.04 [1.00, 1.07]
5.2 Trials with high risk of bias 15 50370 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.86, 1.00]
6 Mortality after excluding factorial trials with potential confounding 52 60544 Risk Ratio (M‐H, Random, 95% CI) 1.01 [0.94, 1.08]
6.1 Trials with low risk of bias 38 52955 Risk Ratio (M‐H, Random, 95% CI) 1.10 [1.05, 1.15]
6.2 Trials with high risk of bias 14 7589 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.73, 0.97]
7 Mortality after excluding factorial trials with potential confounding and trials with extra supplements 36 53542 Risk Ratio (M‐H, Random, 95% CI) 1.01 [0.92, 1.11]
7.1 Trials with low risk of bias 27 46783 Risk Ratio (M‐H, Random, 95% CI) 1.12 [1.06, 1.18]
7.2 Trials with a high risk of bias 9 6759 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.73, 0.98]
8 Mortality in beta‐carotene trials with a low or high risk of bias 31 195503 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.98, 1.07]
8.1 Trials with a low risk of bias 26 173006 Risk Ratio (M‐H, Random, 95% CI) 1.05 [1.01, 1.09]
8.2 Trials with a high risk of bias 5 22497 Risk Ratio (M‐H, Random, 95% CI) 0.81 [0.62, 1.07]
9 Mortality in vitamin A trials with a low or high risk of bias 18 61190 Risk Ratio (M‐H, Random, 95% CI) 1.04 [0.96, 1.13]
9.1 Trials with a low risk of bias 12 41144 Risk Ratio (M‐H, Random, 95% CI) 1.07 [0.97, 1.18]
9.2 Trials with a high risk of bias 6 20046 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.85, 1.07]
10 Mortality in vitamin C trials with a low or high risk of bias 41 90191 Risk Ratio (M‐H, Random, 95% CI) 1.01 [0.97, 1.05]
10.1 Trials with a low risk of bias 29 65942 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.98, 1.07]
10.2 Trials with a high risk of bias 12 24249 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.84, 1.04]
11 Mortality in vitamin E trials with a low or high risk of bias 64 211957 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.99, 1.04]
11.1 Trials with a low risk of bias 46 171244 Risk Ratio (M‐H, Random, 95% CI) 1.03 [1.00, 1.05]
11.2 Trials with a high risk of bias 18 40713 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.85, 0.99]
12 Mortality in selenium trials with a low or high risk of bias 24 86150 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.91, 1.01]
12.1 Trials with a low risk of bias 17 62740 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.91, 1.03]
12.2 Trials with a high risk of bias 7 23410 Risk Ratio (M‐H, Random, 95% CI) 0.91 [0.81, 1.01]